49536 Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Notices 

healthcare systems or 7–10 LTC chains 

each, respectively, to implement adult 

immunization quality improvement 

interventions. 

Summary of the Award 

Recipient: Council of Medical 

Specialty Societies (CMSS) and the 

Society for Post-Acute and Long-Term 

Care Medicine (AMDA). 

Purpose of the Award: The purpose of 

these awards is to increase COVID–19, 

influenza, and routine vaccines in 

adults with chronic medical conditions 

(e.g., COPD, asthma, diabetes, heart 

disease, cancer, and renal disease), 

increase workplace vaccination 

(occupational health settings), and 

increase vaccination among adults 

working and residing in LTCFs through 

implementation of immunization 

quality improvement interventions. 

CMSS will focus on activities leading to 

adoption of the Standards for Adult 

Immunization Practice in its 45 

societies. AMDA will focus on the same 

with its affiliate organization, the 

Foundation for Post-Acute and LongTerm Care Medicine. CMSS and AMDA 

will develop/update vaccine policy 

statements, develop/promote continuing 

education on adult immunization for 

their membership, and award funds to 

up to 7 subspecialty societies (for 

CMSS) and to the Foundation (for 

AMDA) to systematize routine delivery 

of adult immunizations. CMSS-funded 

subspecialty societies and AMDA’s 

Foundation should fund staff at the 

national level and in regional chapters 

to update vaccination policies and 

encourage use of adult vaccinations as 

quality measures. CMSS subspecialty 

societies and AMDA’s Foundation 

should also contract with 7–10 

healthcare systems or 7–10 LTC chains 

each, respectively, to implement adult 

immunization quality improvement 

interventions. 

Amount of Award: $26,000,000 in 

Federal Fiscal Year (FFY) 2021 funds, 

and an estimated total of $66,000,000 

over the five-year period of 

performance. 

Period of Performance: September 30, 

2021 through September 29, 2026. 

Dated: August 30, 2021. 

Joseph I. Hungate III, 

Deputy Director, Office of Financial 

Resources, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2021–19050 Filed 9–2–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Humanitarian Exemption Approved for 

All Afghan Evacuees Subject to CDC’s 

Global Testing Order 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces a 

blanket humanitarian exemption to the 

agency’s Requirement for Negative PreDeparture COVID–19 Test Result for 

individuals relocating to the United 

States from Afghanistan, including U.S. 

citizens, lawful permanent residents 

(LPRs), third country nationals, and 

Afghans at risk, including Afghan 

Special Immigrant Visa (SIV) applicants. 

DATES: This exemption went into effect 

on August 15, 2021. 

FOR FURTHER INFORMATION CONTACT: 

Tiffany Brown, Deputy Chief of Staff, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–10, Atlanta, GA 30329. Phone: 

404–639–7000. Email: cdcregulations@

cdc.gov. 

SUPPLEMENTARY INFORMATION: On 

January 12, 2021, CDC announced an 

Order requiring all air passengers 

arriving to the U.S. from a foreign 

country to get tested no more than 3 

days before their flight departs and to 

present the negative result or 

documentation of having recovered 

from COVID–19 to the airline before 

boarding the flight. 

In August 2021, the U.S. Department 

of State (DOS) issued a series of Security 

Alerts for Afghanistan due to increased 

Taliban activity throughout the country, 

including the capital of Kabul. In 

response to a request from DOS on 

August 15, 2021, CDC and the U.S. 

Department of Health and Human 

Services (HHS) granted a blanket 

humanitarian exemption to CDC’s Order 

to expedite the evacuation of U.S. 

citizens, lawful permanent residents 

(LPRs), third country nationals, and 

Afghans at risk, including Afghan 

Special Immigrant Visa (SIV) applicants, 

while adhering to COVID–19 mitigation 

guidance issued by CDC. 

The exemption, which is being 

administered by DOS and cooperating 

federal and state agencies, was granted 

with the following conditions: (1) The 

CDC Order requiring mask use for 

passengers and crew on air conveyances 

bound for the United States should be 

followed to the extent possible; (2) all 

efforts should be made to test and 

provide test documentation to the 

traveler at a transit location prior to 

arrival in the United States that can be 

presented upon arrival, and if this 

cannot be done, individuals (travelers) 

arriving are required to undergo 

COVID–19 testing immediately upon 

arrival to the first port of entry in the 

United States; (3) individuals who test 

positive are required to isolate prior to 

continuing on commercial 

transportation to their final destination; 

and (4) family members of those testing 

positive may require adhering to selfquarantine recommendations as 

stipulated by CDC or state and local 

health authorities at the arrival location. 

In addition, all Afghan evacuees 

covered by the exemption must also 

agree to comply with relevant CDC posttravel public health guidance including: 

• Watch their health for symptoms of 

COVID–19. If they become ill during the 

flight to the United States or while in a 

U.S. airport, they should immediately 

report their illness. 

• Take all the necessary steps to 

protect themselves and others during 

travel, such as wearing a mask to keep 

their nose and mouth covered when in 

public settings, including on public 

transportation and in airports and other 

transportation hubs until they arrive at 

their final destination. 

• Avoid being around people who are 

at increased risk for severe illness for 14 

days. 

• Follow all federal, state, territorial, 

and local requirements and all other 

public health measures for preventing 

community transmission of COVID–19. 

Authority: The CDC Director is 

issuing this Notice pursuant to Sections 

361 of the Public Health Service Act, 42 

U.S.C. 264, and implementing 

regulations at 42 CFR 71.20 and 

71.31(b). 

Dated: August 31, 2021. 

Sherri Berger, 

Chief of Staff, Centers for Disease Control 

and Prevention. 

[FR Doc. 2021–19089 Filed 9–2–21; 8:45 am] 

BILLING CODE 4163–18–P 


lotter on DSK11XQN23PROD with NOTICES1